Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Ophthalmology

Staying Vigilant: Monitoring, Daily Care, and Emergencies

At a Glance

Euthyroid Graves orbitopathy can affect the eyes even when thyroid levels are normal, and thyroid function may change later. Regular thyroid tests and daily eye protection matter; new color loss, vision changes, blind spots, severe pain, or cloudy vision need same-day care.

Living with Euthyroid Graves Orbitopathy (EGO) means managing a condition where your thyroid hormone function is currently normal, but you are experiencing the immune-mediated symptoms of Thyroid Eye Disease (TED). While your thyroid hormones are presently normal, the goal of long-term care is to protect your vision, manage daily discomfort, and stay vigilant for future changes in your thyroid health.

Emergency Warning Signs: When to Seek Immediate Care

Most symptoms of EGO, such as morning eyelid swelling or a feeling of “fullness” around the eyes, are not emergencies. However, two specific complications require an unambiguous, same-day action plan. Contact an ophthalmologist immediately or go to the nearest emergency department if your specialist is unavailable.

1. Dysthyroid Optic Neuropathy (DON)

This occurs when the swollen muscles or fat behind the eye compress the optic nerve, the “cable” that carries visual information to the brain. This is a sight-threatening emergency [1][2]. DON can be completely painless. Do not wait for multiple signs to appear.

Watch for:

  • Washed-out Colors: Colors (especially red) appear dim, grey, or less vibrant in one or both eyes [2][3].
  • Vision Loss: Sudden or progressive dimness or blurring of vision that cannot be corrected with glasses or blinking [1].
  • Blind Spots: New dark or “missing” patches in your central or peripheral vision [2].

2. Severe Corneal Exposure

If your eyelids cannot close fully (lagophthalmos) due to bulging or retracted lids, the surface of your eye (the cornea) can dry out and break down [4][5].

Watch for:

  • Intense Pain: A sharp, stabbing, or constant “foreign body” sensation [6].
  • Marked Redness: Deep redness that does not improve with standard eye drops.
  • Cloudy Vision: A white or cloudy spot on the clear front part of the eye [7].

While seeking care for exposure symptoms, use preservative-free lubrication or ointment if previously recommended by your doctor, noting that ointment will temporarily blur your vision.

Long-Term Thyroid Monitoring

Being “euthyroid” (having normal thyroid levels) today does not guarantee your thyroid will stay that way. Your immune system is already producing antibodies that can eventually change how your thyroid gland functions [8].

Research from specific clinical cohorts shows that approximately 24% of euthyroid TED patients developed an overactive thyroid (hyperthyroidism) later, and about 3% developed an underactive thyroid (hypothyroidism) [9]. Because these changes can happen years after your eye symptoms start, you will need periodic blood tests (TSH and Free T4) based on an individualized schedule for the foreseeable future [10][11].

Daily Management Strategies

For the day-to-day management of mild or chronic symptoms, several evidence-based steps can improve your comfort:

  • Strict Smoking Cessation: Smoking is the most significant modifiable risk factor. It makes the disease more severe, lasts longer, and reduces the effectiveness of treatments [12][13].
  • Preservative-Free Lubricants: Use preservative-free artificial tears during the day. For nighttime, use a thicker lubricating gel or ointment to keep the eyes moist while you sleep [14][6].
  • Head Elevation: Sleep with the head of your bed elevated (using extra pillows or a wedge). This uses gravity to help drain fluid from the eye sockets, reducing the swelling many patients feel upon waking [15].
  • Light Protection: Use dark sunglasses or tinted lenses to manage photophobia (light sensitivity) and protect your eyes from wind and dust [14].
  • Selenium: In some regions, a 6-month course of selenium supplements may help mild, active disease, but this should only be done under a doctor’s guidance as it is most effective in people who are selenium-deficient. Do not exceed the recommended dose due to toxicity risks, and never self-start selenium without clinician guidance [16][17].

Consistent daily care and a high level of “red flag” awareness are your best tools for preserving your vision and comfort while living with EGO.

Common questions in this guide

What vision changes mean I need emergency care with euthyroid Graves orbitopathy?
New washed-out colors, especially red, sudden or worsening dim or blurred vision, and new blind spots can signal pressure on the optic nerve. This can happen without pain, so contact an ophthalmologist immediately or go to an emergency department if the specialist is unavailable.
Can serious thyroid eye disease damage happen without eye pain?
Yes. Dysthyroid optic neuropathy can be painless, and waiting for several symptoms could risk vision. Any new or progressive loss of vision, reduced color brightness, or blind spots needs same-day assessment.
What are signs that eyelid exposure needs urgent attention?
Intense or constant eye pain, a foreign-body feeling, deep redness that does not improve with ordinary drops, or a white or cloudy spot on the cornea can indicate severe exposure. Seek urgent ophthalmic care, and use preservative-free drops or prescribed ointment while arranging care if your clinician has recommended them.
How often should I have thyroid blood tests if my thyroid is normal now?
There is no single schedule for everyone; testing should be individualized and continue periodically because thyroid function can change years after eye symptoms begin. TSH and Free T4 are the blood tests used to check for later overactive or underactive thyroid function.
What daily habits can make euthyroid Graves orbitopathy symptoms more comfortable?
Stop smoking, use preservative-free artificial tears during the day, and use thicker gel or ointment at night when advised. Elevating your head during sleep and wearing dark or tinted sunglasses can also reduce morning swelling, wind or dust irritation, and light sensitivity.
Could selenium help my thyroid eye disease?
A supervised six-month course may help some people with mild, active disease, particularly when selenium levels are low. It is not appropriate for everyone, and excess selenium can be toxic, so do not start it or exceed the recommended dose without clinician guidance.
What should I do if I cannot fully close my eyelids while sleeping?
Incomplete eyelid closure can expose the cornea to drying and damage. Tell your eye clinician, use preservative-free lubrication or prescribed nighttime ointment if recommended, and seek urgent care for intense pain, marked redness, or cloudy vision.

Get notified when new evidence is published on Euthyroid Graves orbitopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Dysthyroid Optic Neuropathy.

    Potvin ARGG, Pakdel F, Saeed P

    Ophthalmic plastic and reconstructive surgery 2023; (39(6S)):S65-S80 doi:10.1097/IOP.0000000000002555.

    PMID: 38054987
  2. 2

    Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.

    Tramunt B, Imbert P, Grunenwald S, et al.

    Clinical endocrinology 2019; (90(1)):208-213 doi:10.1111/cen.13880.

    PMID: 30339291
  3. 3

    A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency.

    Garip Kuebler A, Halfter K, Reznicek L, et al.

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2021; (259(11)):3421-3426 doi:10.1007/s00417-021-05227-8.

    PMID: 34159407
  4. 4

    Nonsurgical management of upper eyelid retraction in thyroid eye disease.

    Young SM, Kim YD, Woo KI

    Taiwan journal of ophthalmology 2024; (14(4)):548-553 doi:10.4103/tjo.TJO-D-23-00043.

    PMID: 39803393
  5. 5

    Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.

    Gupta V, Hammond CL, Roztocil E, et al.

    Survey of ophthalmology 2022; (67(3)):858-874 doi:10.1016/j.survophthal.2021.08.010.

    PMID: 34487739
  6. 6

    Approach to the patient: therapeutic mitigation of lacrimal manifestations in thyroid eye disease.

    Reinhardt C, Fotovat N, Siddiqui O, et al.

    The Journal of clinical endocrinology and metabolism 2026; (111(5)):e1435-e1445 doi:10.1210/clinem/dgag045.

    PMID: 41649397
  7. 7

    An update on thyroid-associated ophthalmopathy in children and adolescents.

    Szczapa-Jagustyn J, Gotz-Więckowska A, Kocięcki J

    Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(10)):1115-1122.

    PMID: 27682712
  8. 8

    Thyroid antibody-negative euthyroid Graves' ophthalmopathy.

    Tabasum A, Khan I, Taylor P, et al.

    Endocrinology, diabetes & metabolism case reports 2016; (2016()):160008 doi:10.1530/EDM-16-0008.

    PMID: 27284451
  9. 9

    Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease.

    Suzuki N, Noh JY, Kameda T, et al.

    Clinical ophthalmology (Auckland, N.Z.) 2018; (12()):739-746 doi:10.2147/OPTH.S158967.

    PMID: 29719374
  10. 10

    Euthyroid graves' ophthalmopathy in a Chinese population: A cross-sectional follow-up study.

    Lai KK, Ali Abdulla Aljufairi FM, Sebastian JU, et al.

    European journal of ophthalmology 2024; (34(5)):1432-1437 doi:10.1177/11206721241229470.

    PMID: 38444235
  11. 11

    Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature.

    Muñoz-Ortiz J, Sierra-Cote MC, Zapata-Bravo E, et al.

    Systematic reviews 2020; (9(1)):201 doi:10.1186/s13643-020-01459-7.

    PMID: 32873324
  12. 12

    Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors.

    Bartalena L, Gallo D, Tanda ML, Kahaly GJ

    Ophthalmic plastic and reconstructive surgery 2023; (39(6S)):S2-S8 doi:10.1097/IOP.0000000000002467.

    PMID: 38054980
  13. 13

    Evaluation of clinical and ocular surface changes in thyroid eye disease: impact of treatment and risk factors.

    Barman Kakil Ş, Arslan N

    Therapeutic advances in ophthalmology 2025; (17()):25158414251393119 doi:10.1177/25158414251393119.

    PMID: 41322343
  14. 14

    The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.

    Bartalena L, Baldeschi L, Boboridis K, et al.

    European thyroid journal 2016; (5(1)):9-26 doi:10.1159/000443828.

    PMID: 27099835
  15. 15

    Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.

    Mellington FE, Dayan CM, Dickinson AJ, et al.

    Orbit (Amsterdam, Netherlands) 2017; (36(3)):159-169 doi:10.1080/01676830.2017.1280057.

    PMID: 28296512
  16. 16

    Selenium supplementation in thyroid eye disease: an updated review from a clinical ophthalmic perspective.

    Foos W, Maliakkal Hernandez J, Mansour TN

    Orbit (Amsterdam, Netherlands) 2024; (43(6)):790-800 doi:10.1080/01676830.2023.2276783.

    PMID: 37976183
  17. 17

    Selenium in thyroid disorders - essential knowledge for clinicians.

    Winther KH, Rayman MP, Bonnema SJ, Hegedüs L

    Nature reviews. Endocrinology 2020; (16(3)):165-176 doi:10.1038/s41574-019-0311-6.

    PMID: 32001830

This page is for informational purposes only and does not constitute medical advice. An ophthalmologist and the clinician managing your thyroid health should tailor your plan; seek same-day care for new vision or color changes, blind spots, severe eye pain, or cloudy vision.